Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement
Details
Publication Year 2022-06,Volume 54,Issue #4,Page 389-398
Journal Title
Pathology
Publication Type
Review
Abstract
This review aims to provide an expert consensus statement to address the role of gene-panel testing in the diagnosis, prognosis and management of adult myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes (MDS/MPN) in Australia. This consensus statement was developed by an expert group, actively involved in gene panel testing in the area of MDS/MPN in Australia. This work was led by the chairs of the MDS (A/Prof A. Enjeti) and MPN (A/Prof D. Ross) working parties of the Australasian Leukaemia and Lymphoma Group (ALLG). The authors were selected after an expression of interest process on the basis of active laboratory involvement in gene panel testing, a specific demonstrated interest in MDS/MPN and/or publication record in this field. The authors were then allocated sections for literature review to identify the specific genes of interest for each MDS/MPN entity. At least two authors reviewed each section and an overarching diagnostic algorithm was developed by a consensus amongst all authors.
Keywords
Humans; *Leukemia/diagnosis/genetics; *Lymphoma; Mutation; *Myelodysplastic Syndromes/diagnosis/genetics/metabolism; *Myelodysplastic-Myeloproliferative Diseases/diagnosis/genetics; *Myeloproliferative Disorders/genetics; Myelodysplasia; Ngs; consensus; gene panel; myeloproliferative neoplasms
Department(s)
Pathology; Haematology
PubMed ID
35461716
Open Access at Publisher's Site
https://doi.org/10.1016/j.pathol.2022.03.002
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-10-24 04:09:57
Last Modified: 2024-10-24 04:10:44

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙